Using a novel purification method we demonstrate for the first time that tumor cells isolated from the ascites of recurrent ovarian cancer patients are enriched with EPCAM+++/STAT3+++ tumor cells compared to cells isolated from the ascites of CN patients. This evidence concerns the gene EPCAM and ovarian carcinoma.